The Ocata Preclinical Pipeline, Part 3: Mesenchymal Stem Cells – Seeking Alpha
|
The Ocata Preclinical Pipeline, Part 3: Mesenchymal Stem Cells
Seeking Alpha Mesenchymal stem cells represent a promising therapeutic strategy for a variety of immune-related diseases. Favorable preclinical results have been reported by Ocata in models of multiple sclerosis, lupus, and other autoimmune disorders. This article … |
